Miller Joseph M
- SEC CIK
- 0001746372
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.Chief Financial Officeras of Mar 3, 2026
- AVTX Avalo Therapeutics, Inc.Directoras of Apr 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Miller Joseph M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AUPH Aurinia Pharmaceuticals Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 (view filing) | Mar 3-4 | 1 day | Miller Joseph MChief Financial Officer | SSale | −118.0K | $7.96 | −$939.6K | −17.0%577.4K after | 2 lots |
| Mar 7, 2024 (view filing) | Mar 6 | 1 day | Miller Joseph MChief Financial Officer | SSale | −34.8K | $5.60 | −$194.9K | −6.6%495.9K after | |
| Feb 22, 2024 (view filing) | Mar 2, 2023 | 357 days | Miller Joseph MChief Financial Officer | SSale | −11.4K | $8.78 | −$100.1K | −3.3%331.1K after | Amended |
| Mar 4, 2022 (view filing) | Mar 2 | 2 days | Miller Joseph MChief Financial Officer | SSale | −3.06K | $12.01 | −$36.8K | −31.6%6.61K after |